BindingDB logo
myBDB logout

BDBM50115617 CHEMBL3609257

SMILES: [H][C@@]12CCCN1C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@]([H])(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)CNC(=O)[C@]1([H])CSSC[C@]3([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@]([H])(NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4cccc5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC

InChI Key: InChIKey=IOXBFRBDDWONMY-KYUINLTESA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50115617   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kcal/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Voltage-gated potassium channel


(Homo sapiens (Human))		BDBM50115617
PNG
(CHEMBL3609257)
Show SMILES [H][C@@]12CCCN1C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@]([H])(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)CNC(=O)[C@]1([H])CSSC[C@]3([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@]([H])(NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4cccc5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC |r|
Show InChI InChI=1S/C179H280N54O47S7/c1-13-91(5)136-169(273)217-122(77-135(244)245)160(264)231-141(97(11)240)173(277)229-137(92(6)14-2)174(278)233-69-36-53-132(233)168(272)210-109(48-25-29-63-182)149(253)219-124(81-235)161(265)205-113(52-35-68-198-179(192)193)150(254)222-130-87-285-284-85-128-165(269)207-111(50-33-66-196-177(188)189)145(249)203-110(49-26-30-64-183)153(257)230-140(96(10)239)172(276)225-126(144(248)199-79-134(243)227-138(94(8)237)171(275)226-131(175(279)280)88-287-286-86-129(166(270)228-136)224-163(267)123(80-234)218-143(247)106(184)45-32-65-195-176(186)187)83-282-283-84-127(221-151(255)114(58-59-133(185)242)208-155(259)117(72-98-37-17-15-18-38-98)211-142(246)93(7)201-170(274)139(95(9)238)232-167(130)271)164(268)206-108(47-24-28-62-181)147(251)216-121(76-103-78-194-89-200-103)159(263)220-125(82-236)162(266)209-115(60-70-281-12)152(256)202-107(46-23-27-61-180)146(250)213-119(74-100-54-56-104(241)57-55-100)156(260)204-112(51-34-67-197-178(190)191)148(252)212-116(71-90(3)4)154(258)215-120(75-102-43-31-42-101-41-21-22-44-105(101)102)158(262)214-118(157(261)223-128)73-99-39-19-16-20-40-99/h15-22,31,37-44,54-57,78,89-97,106-132,136-141,234-241H,13-14,23-30,32-36,45-53,58-77,79-88,180-184H2,1-12H3,(H2,185,242)(H,194,200)(H,199,248)(H,201,274)(H,202,256)(H,203,249)(H,204,260)(H,205,265)(H,206,268)(H,207,269)(H,208,259)(H,209,266)(H,210,272)(H,211,246)(H,212,252)(H,213,250)(H,214,262)(H,215,258)(H,216,251)(H,217,273)(H,218,247)(H,219,253)(H,220,263)(H,221,255)(H,222,254)(H,223,261)(H,224,267)(H,225,276)(H,226,275)(H,227,243)(H,228,270)(H,229,277)(H,230,257)(H,231,264)(H,232,271)(H,244,245)(H,279,280)(H4,186,187,195)(H4,188,189,196)(H4,190,191,197)(H4,192,193,198)/t91-,92-,93-,94+,95+,96+,97+,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,136-,137-,138-,139-,140-,141-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/a 207n/an/an/an/an/an/a



Amgen Inc.

Curated by ChEMBL


Assay Description
Antagonist activity at human Kv1.3 expressed in CHOK1 cells assessed as inhibition of potassium currents after 10 mins by IonWorks Quattro patch clam...

J Med Chem 58: 6784-802 (2015)


BindingDB Entry DOI: 10.7270/Q22V2HWG
More data for this
Ligand-Target Pair
Voltage-gated potassium channel


(Homo sapiens (Human))		BDBM50115617
PNG
(CHEMBL3609257)
Show SMILES [H][C@@]12CCCN1C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@]([H])(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)CNC(=O)[C@]1([H])CSSC[C@]3([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@]([H])(NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4cccc5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC |r|
Show InChI InChI=1S/C179H280N54O47S7/c1-13-91(5)136-169(273)217-122(77-135(244)245)160(264)231-141(97(11)240)173(277)229-137(92(6)14-2)174(278)233-69-36-53-132(233)168(272)210-109(48-25-29-63-182)149(253)219-124(81-235)161(265)205-113(52-35-68-198-179(192)193)150(254)222-130-87-285-284-85-128-165(269)207-111(50-33-66-196-177(188)189)145(249)203-110(49-26-30-64-183)153(257)230-140(96(10)239)172(276)225-126(144(248)199-79-134(243)227-138(94(8)237)171(275)226-131(175(279)280)88-287-286-86-129(166(270)228-136)224-163(267)123(80-234)218-143(247)106(184)45-32-65-195-176(186)187)83-282-283-84-127(221-151(255)114(58-59-133(185)242)208-155(259)117(72-98-37-17-15-18-38-98)211-142(246)93(7)201-170(274)139(95(9)238)232-167(130)271)164(268)206-108(47-24-28-62-181)147(251)216-121(76-103-78-194-89-200-103)159(263)220-125(82-236)162(266)209-115(60-70-281-12)152(256)202-107(46-23-27-61-180)146(250)213-119(74-100-54-56-104(241)57-55-100)156(260)204-112(51-34-67-197-178(190)191)148(252)212-116(71-90(3)4)154(258)215-120(75-102-43-31-42-101-41-21-22-44-105(101)102)158(262)214-118(157(261)223-128)73-99-39-19-16-20-40-99/h15-22,31,37-44,54-57,78,89-97,106-132,136-141,234-241H,13-14,23-30,32-36,45-53,58-77,79-88,180-184H2,1-12H3,(H2,185,242)(H,194,200)(H,199,248)(H,201,274)(H,202,256)(H,203,249)(H,204,260)(H,205,265)(H,206,268)(H,207,269)(H,208,259)(H,209,266)(H,210,272)(H,211,246)(H,212,252)(H,213,250)(H,214,262)(H,215,258)(H,216,251)(H,217,273)(H,218,247)(H,219,253)(H,220,263)(H,221,255)(H,222,254)(H,223,261)(H,224,267)(H,225,276)(H,226,275)(H,227,243)(H,228,270)(H,229,277)(H,230,257)(H,231,264)(H,232,271)(H,244,245)(H,279,280)(H4,186,187,195)(H4,188,189,196)(H4,190,191,197)(H4,192,193,198)/t91-,92-,93-,94+,95+,96+,97+,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,136-,137-,138-,139-,140-,141-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/a 573n/an/an/an/an/an/a



Amgen Inc.

Curated by ChEMBL


Assay Description
Antagonist activity at Kv1.3 in human whole blood assessed as inhibition of thapsigargin-induced IFN-gamma secretion incubated for 30 prior to thapsi...

J Med Chem 58: 6784-802 (2015)


BindingDB Entry DOI: 10.7270/Q22V2HWG
More data for this
Ligand-Target Pair
Voltage-gated potassium channel


(Homo sapiens (Human))		BDBM50115617
PNG
(CHEMBL3609257)
Show SMILES [H][C@@]12CCCN1C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@]([H])(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)CNC(=O)[C@]1([H])CSSC[C@]3([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@]([H])(NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4cccc5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC |r|
Show InChI InChI=1S/C179H280N54O47S7/c1-13-91(5)136-169(273)217-122(77-135(244)245)160(264)231-141(97(11)240)173(277)229-137(92(6)14-2)174(278)233-69-36-53-132(233)168(272)210-109(48-25-29-63-182)149(253)219-124(81-235)161(265)205-113(52-35-68-198-179(192)193)150(254)222-130-87-285-284-85-128-165(269)207-111(50-33-66-196-177(188)189)145(249)203-110(49-26-30-64-183)153(257)230-140(96(10)239)172(276)225-126(144(248)199-79-134(243)227-138(94(8)237)171(275)226-131(175(279)280)88-287-286-86-129(166(270)228-136)224-163(267)123(80-234)218-143(247)106(184)45-32-65-195-176(186)187)83-282-283-84-127(221-151(255)114(58-59-133(185)242)208-155(259)117(72-98-37-17-15-18-38-98)211-142(246)93(7)201-170(274)139(95(9)238)232-167(130)271)164(268)206-108(47-24-28-62-181)147(251)216-121(76-103-78-194-89-200-103)159(263)220-125(82-236)162(266)209-115(60-70-281-12)152(256)202-107(46-23-27-61-180)146(250)213-119(74-100-54-56-104(241)57-55-100)156(260)204-112(51-34-67-197-178(190)191)148(252)212-116(71-90(3)4)154(258)215-120(75-102-43-31-42-101-41-21-22-44-105(101)102)158(262)214-118(157(261)223-128)73-99-39-19-16-20-40-99/h15-22,31,37-44,54-57,78,89-97,106-132,136-141,234-241H,13-14,23-30,32-36,45-53,58-77,79-88,180-184H2,1-12H3,(H2,185,242)(H,194,200)(H,199,248)(H,201,274)(H,202,256)(H,203,249)(H,204,260)(H,205,265)(H,206,268)(H,207,269)(H,208,259)(H,209,266)(H,210,272)(H,211,246)(H,212,252)(H,213,250)(H,214,262)(H,215,258)(H,216,251)(H,217,273)(H,218,247)(H,219,253)(H,220,263)(H,221,255)(H,222,254)(H,223,261)(H,224,267)(H,225,276)(H,226,275)(H,227,243)(H,228,270)(H,229,277)(H,230,257)(H,231,264)(H,232,271)(H,244,245)(H,279,280)(H4,186,187,195)(H4,188,189,196)(H4,190,191,197)(H4,192,193,198)/t91-,92-,93-,94+,95+,96+,97+,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,136-,137-,138-,139-,140-,141-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/a 357n/an/an/an/an/an/a



Amgen Inc.

Curated by ChEMBL


Assay Description
Antagonist activity at Kv1.3 in human whole blood assessed as inhibition of thapsigargin-induced IL-2 secretion incubated for 30 prior to thapsigargi...

J Med Chem 58: 6784-802 (2015)


BindingDB Entry DOI: 10.7270/Q22V2HWG
More data for this
Ligand-Target Pair
Voltage-gated potassium channel


(Homo sapiens (Human))		BDBM50115617
PNG
(CHEMBL3609257)
Show SMILES [H][C@@]12CCCN1C(=O)[C@@]([H])(NC(=O)[C@@]([H])(NC(=O)[C@H](CC(O)=O)NC(=O)[C@@]([H])(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)CNC(=O)[C@]1([H])CSSC[C@]3([H])NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@]([H])(NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4cccc5ccccc45)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@H](CCCCN)NC3=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC2=O)[C@@H](C)O)[C@@H](C)O)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC |r|
Show InChI InChI=1S/C179H280N54O47S7/c1-13-91(5)136-169(273)217-122(77-135(244)245)160(264)231-141(97(11)240)173(277)229-137(92(6)14-2)174(278)233-69-36-53-132(233)168(272)210-109(48-25-29-63-182)149(253)219-124(81-235)161(265)205-113(52-35-68-198-179(192)193)150(254)222-130-87-285-284-85-128-165(269)207-111(50-33-66-196-177(188)189)145(249)203-110(49-26-30-64-183)153(257)230-140(96(10)239)172(276)225-126(144(248)199-79-134(243)227-138(94(8)237)171(275)226-131(175(279)280)88-287-286-86-129(166(270)228-136)224-163(267)123(80-234)218-143(247)106(184)45-32-65-195-176(186)187)83-282-283-84-127(221-151(255)114(58-59-133(185)242)208-155(259)117(72-98-37-17-15-18-38-98)211-142(246)93(7)201-170(274)139(95(9)238)232-167(130)271)164(268)206-108(47-24-28-62-181)147(251)216-121(76-103-78-194-89-200-103)159(263)220-125(82-236)162(266)209-115(60-70-281-12)152(256)202-107(46-23-27-61-180)146(250)213-119(74-100-54-56-104(241)57-55-100)156(260)204-112(51-34-67-197-178(190)191)148(252)212-116(71-90(3)4)154(258)215-120(75-102-43-31-42-101-41-21-22-44-105(101)102)158(262)214-118(157(261)223-128)73-99-39-19-16-20-40-99/h15-22,31,37-44,54-57,78,89-97,106-132,136-141,234-241H,13-14,23-30,32-36,45-53,58-77,79-88,180-184H2,1-12H3,(H2,185,242)(H,194,200)(H,199,248)(H,201,274)(H,202,256)(H,203,249)(H,204,260)(H,205,265)(H,206,268)(H,207,269)(H,208,259)(H,209,266)(H,210,272)(H,211,246)(H,212,252)(H,213,250)(H,214,262)(H,215,258)(H,216,251)(H,217,273)(H,218,247)(H,219,253)(H,220,263)(H,221,255)(H,222,254)(H,223,261)(H,224,267)(H,225,276)(H,226,275)(H,227,243)(H,228,270)(H,229,277)(H,230,257)(H,231,264)(H,232,271)(H,244,245)(H,279,280)(H4,186,187,195)(H4,188,189,196)(H4,190,191,197)(H4,192,193,198)/t91-,92-,93-,94+,95+,96+,97+,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,136-,137-,138-,139-,140-,141-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/a 1.02E+3n/an/an/an/an/an/a



Amgen Inc.

Curated by ChEMBL


Assay Description
Antagonist activity at human Kv1.1 expressed in HEK293 cells assessed as inhibition of potassium currents after 10 mins by IonWorks Quattro patch cla...

J Med Chem 58: 6784-802 (2015)


BindingDB Entry DOI: 10.7270/Q22V2HWG
More data for this
Ligand-Target Pair